Skip to main content

Latest SEC Filings — Page 46

Most recent SEC EDGAR filings across all covered tickers, sorted chronologically. Wiseek AI reads each filing and scores it 1–10 for market-moving potential; click through for full analysis.

How Wiseek curates this list

Every filing on this page is sourced directly from SEC EDGAR, the U.S. Securities and Exchange Commission's public filings system. Wiseek processes 8-K, 10-K, 10-Q, Form 4, Form 144, DEF 14A, Schedule 13D/A and related disclosures filed by U.S.-listed companies. The original filing is always linked from each article so readers can verify the source document directly.

How filings get scored

Each filing runs through Wiseek's importance scorer, which weights filing type, deal magnitude, insider participation, material-event flags (going-concern, restatements, executive transitions, M&A) and historical market-reaction patterns. Filings scoring below 7 on the 1–10 scale are filtered out at the database query so this list stays focused on market-moving disclosures. See our methodology for the full rubric.

Editorial standards

Wiseek does not edit the underlying SEC filing. Plain-English summaries and key-event extractions are generated from the verified source text and clearly attributed as AI-generated. Wiseek does not provide investment advice — see our editorial policy for full standards on accuracy, source disclosure, and corrections.

Track by company

Follow all SEC filings for a specific company by visiting its ticker page: AAPL, MSFT, NVDA, TSLA, AMZN, GOOGL, META, JPM, V, UNH, XOM, AVGO, LLY, MA, COST, JNJ, PG, HD, ABBV, MRK, KO, NFLX, AMD, WMT, CVX, BAC — or browse all covered tickers.

Shell Pauses $3.0 Billion Share Buyback Program Due to ARC Acquisition Requirements
Form 6-KSHEL · Form 6-K · 6d ago
Fox Corporation to Acquire Roku for $22 Billion in Cash and Stock
ProForm 425ROKU · Form 425 · 6d ago
Nano Dimension to Acquire Infinite Epigenetics in $890M Deal, Pivoting to AI-Powered Health
ProForm 8-KNNDM · Form 8-K · 6d ago
Roku to be Acquired by Fox Corporation for $22 Billion in Cash and Stock
ProForm 8-KROKU · Form 8-K · 6d ago
EVP Sells $287K in ZIM Shares, Continuing Insider Sale Trend
Form 4ZIM · Form 4 · 6d ago
BRC Group Discloses $70.4M Net Carried Interest in SpaceX Post-IPO
ProForm 8-KRILY · Form 8-K · 6d ago
Dragonfly Energy Secures European Patent for Dry Electrode Manufacturing
Form 8-KDFLI · Form 8-K · 6d ago
OwlTing Partners with Credible Finance to Open China Payment Corridor; OwlPay Harbor Client Base Surges
ProForm 6-KOWLS · Form 6-K · 6d ago
Jack in the Box Finalizes $500M Securitized Debt Refinancing at Higher 7.624% Rate
ProForm 8-KJACK · Form 8-K · 6d ago
Zevia Appoints New CEO Alexandre Ruberti; Raises Q2 Sales & EBITDA Guidance
ProForm 8-KZVIA · Form 8-K · 6d ago
Innovex Acquires TCO Group for $95M, Expects 13% EPS Accretion
ProForm 8-KINVX · Form 8-K · 6d ago
Two Harbors Reaffirms CCM Merger After Rival UWMC Fails to Submit Proposal
ProForm DEFA14ATWO · Form DEFA14A · 6d ago
Steakholder Foods Registers Resale of 1.85M ADSs, Potential 100%+ Dilution from Warrant Repricing
ProForm F-3STKH · Form F-3 · 6d ago
Two Harbors Board Rejects UWMC's Latest Offer, Reaffirms Commitment to $12.00 All-Cash CCM Merger
ProForm DEFA14ATWO · Form DEFA14A · 6d ago
Fermi Board Files Definitive Revocation Statement, Fights Former CEO's Proxy Bid Amidst Financial Distress
ProForm DEFA14AFRMI · Form DEFA14A · 6d ago
Fox Corporation to Acquire Roku for $22 Billion in Transformational Deal
ProForm 425FOXA · Form 425 · 6d ago
Enhanced Group Secures $50M PIPE Financing with Insider Participation to Fund Growth to Profitability
ProForm 8-KENHA · Form 8-K · 6d ago
Fox Corp to Acquire Roku for $22 Billion, Creating Scaled Media & Tech Platform
ProForm 8-KFOXA · Form 8-K · 6d ago
DOE Mandates Centralia Unit 2 Remain Operational for 90 Days
Form 6-KTAC · Form 6-K · 6d ago
Ascentage Pharma Presents Positive Clinical Data for Olverembatinib and Lisaftoclax at EHA2026
ProForm 6-KAAPG · Form 6-K · 6d ago
Alkermes' Alixorexton Receives Orphan Drug Designations in US & EU for Hypersomnia & Narcolepsy
Form 8-KALKS · Form 8-K · 6d ago
Lexeo Finalizes Pivotal Trial Design for LX2006 in Friedreich Ataxia, Targets Accelerated FDA Approval by 1H 2028
ProForm 8-KLXEO · Form 8-K · 6d ago
Honeywell Board Approves Aerospace Spin-Off, Declares Distribution, and Confirms Director Transitions
ProForm 8-KHON · Form 8-K · 6d ago
Elite Pharma Reports Positive Bioequivalence for $840M Anticonvulsant Generic
ProForm 8-KELTP · Form 8-K · 6d ago
Coda Octopus Group Reports Strong Q2 EPS Beat Amidst Revenue Decline and Geopolitical Headwinds
Form 10-QCODA · Form 10-Q · 6d ago
Semnur Pharmaceuticals Registers Over 211 Million Shares for Sale/Issuance Amidst Going Concern Warning
ProForm 424B3SMNR · Form 424B3 · 6d ago
SPAC Sponsor & CEO Disclose 21% Stake Post-IPO, Confirming Commitment
ProForm SCHEDULE 13DIPVVU · Form SCHEDULE 13D · 6d ago
XORTX Appoints Co-CEO, Details Path to NDA for Gout Drug XRx-026
ProForm 6-KXRTX · Form 6-K · 6d ago
Peabody Secures A$700M Surety Bonds, Boosts Liquidity
ProForm 8-KBTU · Form 8-K · 6d ago
Kanzhun Cancels 24.3M Repurchased Shares, Reducing Outstanding Count
ProForm 6-KBZ · Form 6-K · 6d ago